These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10469681)

  • 1. Gonadotrophin and testosterone suppression by 7alpha-methyl-19-nortestosterone acetate administered by subdermal implant to healthy men.
    Noé G; Suvisaari J; Martin C; Moo-Young AJ; Sundaram K; Saleh SI; Quintero E; Croxatto HB; Lähteenmäki P
    Hum Reprod; 1999 Sep; 14(9):2200-6. PubMed ID: 10469681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.
    von Eckardstein S; Noe G; Brache V; Nieschlag E; Croxatto H; Alvarez F; Moo-Young A; Sivin I; Kumar N; Small M; Sundaram K;
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5232-9. PubMed ID: 14602755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 7 alpha-methyl-19-nortestosterone (MENT) delivery using subdermal implants in healthy men.
    Suvisaari J; Moo-Young A; Juhakoski A; Elomaa K; Saleh SI; Lähteenmäki P
    Contraception; 1999 Nov; 60(5):299-303. PubMed ID: 10717782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men.
    Suvisaari J; Sundaram K; Noé G; Kumar N; Aguillaume C; Tsong YY; Lähteenmäki P; Bardin CW
    Hum Reprod; 1997 May; 12(5):967-73. PubMed ID: 9194649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7 alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception.
    Sundaram K; Kumar N; Bardin CW
    Ann Med; 1993 Apr; 25(2):199-205. PubMed ID: 8489761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
    Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men.
    Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA
    J Androl; 2007; 28(5):679-88. PubMed ID: 17460095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of 7 alpha-methyl-19-nortestosterone in men and cynomolgus monkeys.
    Kumar N; Suvisaari J; Tsong YY; Aguillaume C; Bardin CW; Lähteenmaki P; Sundaram K
    J Androl; 1997; 18(4):352-8. PubMed ID: 9283946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7Alpha-methyl-19-nortestosterone maintains sexual behavior and mood in hypogonadal men.
    Anderson RA; Martin CW; Kung AW; Everington D; Pun TC; Tan KC; Bancroft J; Sundaram K; Moo-Young AJ; Baird DT
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3556-62. PubMed ID: 10522995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin.
    Schlegel PN; Kuzma P; Frick J; Farkas A; Gomahr A; Spitz I; Chertin B; Mack D; Jungwirth A; King P; Nash H; Bardin CW; Moo-Young A
    Urology; 2001 Oct; 58(4):578-82. PubMed ID: 11597543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
    Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
    Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic administration of 7alpha-methyl-19-nortestosterone on serum testosterone, number of spermatozoa and fertility in adult male bonnet monkeys (Macaca radiata).
    Ramachandra SG; Ramesh V; Krishnamurthy HN; Kumar N; Sundaram K; Hardy MP; Rao AJ
    Reproduction; 2002 Aug; 124(2):301-9. PubMed ID: 12141943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-sparing effects in primates of the potent androgen 7alpha-methyl-19-nortestosterone: a potential alternative to testosterone for androgen replacement and male contraception.
    Cummings DE; Kumar N; Bardin CW; Sundaram K; Bremner WJ
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4212-9. PubMed ID: 9851754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.
    Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and late long-term effects of vasectomy on serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone levels.
    Mo ZN; Huang X; Zhang SC; Yang JR
    J Urol; 1995 Dec; 154(6):2065-9. PubMed ID: 7500459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception.
    Pöllänen P; Nikkanen V; Huhtaniemi I
    Int J Androl; 2001 Dec; 24(6):369-80. PubMed ID: 11737418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.
    Anderson RA; Wallace AM; Sattar N; Kumar N; Sundaram K
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2784-93. PubMed ID: 12788888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.